CN106868043B - Method for constructing zebra fish intervertebral disc injury model - Google Patents
Method for constructing zebra fish intervertebral disc injury model Download PDFInfo
- Publication number
- CN106868043B CN106868043B CN201710074948.5A CN201710074948A CN106868043B CN 106868043 B CN106868043 B CN 106868043B CN 201710074948 A CN201710074948 A CN 201710074948A CN 106868043 B CN106868043 B CN 106868043B
- Authority
- CN
- China
- Prior art keywords
- twhh
- zebra fish
- intervertebral disc
- fish
- ntr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000252212 Danio rerio Species 0.000 title claims abstract description 66
- 206010055040 Intervertebral disc injury Diseases 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims description 20
- 238000003752 polymerase chain reaction Methods 0.000 claims abstract description 32
- 238000010276 construction Methods 0.000 claims abstract description 27
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 17
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 17
- 230000002441 reversible effect Effects 0.000 claims abstract description 8
- 101150108915 twhh gene Proteins 0.000 claims description 42
- 241000251468 Actinopterygii Species 0.000 claims description 34
- 239000012634 fragment Substances 0.000 claims description 26
- 230000009261 transgenic effect Effects 0.000 claims description 25
- 229960000282 metronidazole Drugs 0.000 claims description 18
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 210000001161 mammalian embryo Anatomy 0.000 claims description 10
- 238000000137 annealing Methods 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 238000004925 denaturation Methods 0.000 claims description 2
- 230000036425 denaturation Effects 0.000 claims description 2
- 230000004720 fertilization Effects 0.000 claims description 2
- 238000012257 pre-denaturation Methods 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims 4
- 210000004602 germ cell Anatomy 0.000 claims 2
- 238000009396 hybridization Methods 0.000 claims 1
- 239000013600 plasmid vector Substances 0.000 claims 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 abstract description 22
- 238000011160 research Methods 0.000 abstract description 18
- 208000018180 degenerative disc disease Diseases 0.000 abstract description 15
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 abstract description 15
- 239000013612 plasmid Substances 0.000 description 73
- 210000004027 cell Anatomy 0.000 description 38
- 101100427031 Danio rerio shhb gene Proteins 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- 238000002474 experimental method Methods 0.000 description 20
- 230000018109 developmental process Effects 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 229910001868 water Inorganic materials 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 238000011161 development Methods 0.000 description 18
- 108091008146 restriction endonucleases Proteins 0.000 description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 17
- 238000010171 animal model Methods 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- 102000004459 Nitroreductase Human genes 0.000 description 14
- 108020001162 nitroreductase Proteins 0.000 description 14
- 239000000872 buffer Substances 0.000 description 13
- 230000007850 degeneration Effects 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- 238000001976 enzyme digestion Methods 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 238000002347 injection Methods 0.000 description 12
- 239000007924 injection Substances 0.000 description 12
- 210000002257 embryonic structure Anatomy 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- 238000012163 sequencing technique Methods 0.000 description 10
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 9
- 230000033558 biomineral tissue development Effects 0.000 description 9
- 230000000366 juvenile effect Effects 0.000 description 9
- 238000000520 microinjection Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000009528 severe injury Effects 0.000 description 9
- 210000000278 spinal cord Anatomy 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000001502 gel electrophoresis Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 238000010186 staining Methods 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229960000723 ampicillin Drugs 0.000 description 6
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 210000000963 osteoblast Anatomy 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 208000037974 severe injury Diseases 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 229920000936 Agarose Polymers 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229930040373 Paraformaldehyde Natural products 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229920002866 paraformaldehyde Polymers 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 4
- 108090000364 Ligases Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- ZYWFEOZQIUMEGL-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol;phenol Chemical compound ClC(Cl)Cl.CC(C)CCO.OC1=CC=CC=C1 ZYWFEOZQIUMEGL-UHFFFAOYSA-N 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- ZMCBYSBVJIMENC-UHFFFAOYSA-N tricaine Chemical compound CCOC(=O)C1=CC=CC(N)=C1 ZMCBYSBVJIMENC-UHFFFAOYSA-N 0.000 description 4
- 239000012137 tryptone Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
- 241000027355 Ferocactus setispinus Species 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 208000015122 neurodegenerative disease Diseases 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000005786 degenerative changes Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000011177 media preparation Methods 0.000 description 2
- 230000009456 molecular mechanism Effects 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 210000003458 notochord Anatomy 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229940072040 tricaine Drugs 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000283070 Equus zebra Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 206010041611 Spine malformation Diseases 0.000 description 1
- 241000519995 Stachys sylvatica Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000005775 apoptotic pathway Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000010603 microCT Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008722 morphological abnormality Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000000270 postfertilization Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a construction method of a zebra fish intervertebral disc injury model, which comprises a DNA polymerase chain reaction and is characterized in that a primer and a sequence used in the DNA polymerase chain reaction are as follows: 5'-GTCGACGTACTGTATCTGTGCTGATTCA C-3', reverse primer: 5'-GACCAGAAGAGATAATTCAAACG T-3' are provided. The invention aims to solve the technical problem of providing a theoretical basis for the intervertebral disc degeneration research and discloses a construction method of a zebra fish intervertebral disc injury model.
Description
Technical Field
The invention relates to the field of genetic engineering, in particular to a construction method of a zebra fish intervertebral disc injury model.
Background
The intervertebral disc degeneration caused by the growth of age and the accumulation of pressure abrasion is a special ageing disease of the spine, 20 percent of low back pain (L BP) can be caused, the intervertebral disc degeneration is a main cause of the occurrence of chronic low back pain, the occurrence, the degeneration and the regeneration and repair of the intervertebral disc are complex processes, the exact molecular biological mechanism is not clear, and the invention relates to influencing factors in many aspects, and is further researched.
The research on the spine degenerative disease is generally carried out by mainly damaging the lumbar intervertebral disc of a mouse through a surgical mode to establish an animal model of intervertebral disc degeneration, but the defects of the modeling are very obvious, such as great surgical trauma and high economic cost, mouse embryos develop in a female mouse, the research on the early development progress of the spine is not facilitated, the animal model is not suitable for the research on the migration and differentiation processes of cells dynamically labeled in real time on a living body, so the animal model mouse is considered to be the representative of a preferred mammal, Hayes and the like take the zebra fish as an animal model for the research on the aged spine malformation, and the research on the characteristics similar to osteoarthritis accompanying with vertebrae through describing the change of age correlation, particularly vertebral cartilage and bone tissues facilitates the research on the spine Creus in the animal model by screening out a novel experimental animal model, so that the research on the pathological change process of the spine degenerative disease can be better understood, the research on the improvement of the existing clinical treatment scheme provides a firmer foundation for the research on the improvement of the spine developmental process of the spine degeneration process of the spine degenerative disease, the spine genetic model is a novel animal model for the research on the development of the spine mineralization of the spine, particularly the research on the spinal bone and the spinal genetic homology of the spine, the spinal cord of the zebra, the animal model is a novel animal model, the research on the development of the spine, the spine mineralization of the spine, the development of the spine, the development of the spine, the research of the spine, the development of the spine, the research of the development.
The invention takes zebra fish as a model animal, constructs the intervertebral disc degeneration model by damaging the intervertebral disc of the zebra fish, and provides a preliminary theoretical basis for further researching the molecular mechanism of intervertebral disc degeneration and vertebra degeneration.
Disclosure of Invention
The invention aims to solve the technical problem of providing a theoretical basis for the intervertebral disc degeneration research and discloses a construction method of a zebra fish intervertebral disc injury model.
In order to solve the technical problems, the invention provides the following technical scheme: the construction method of the zebra fish intervertebral disc injury model comprises a DNA polymerase chain reaction, wherein primers and sequences used in the DNA polymerase chain reaction are as follows:
a forward primer: 5'-GTCGACGTACTGTATCTGTGCTGATTCAC-3'
Reverse primer: 5'-GACCAGAAGAGATAATTCAAACGT-3' are provided.
Further, the reaction system of the DNA polymerase chain reaction is as follows:
furthermore, the reaction process of the DNA polymerase chain reaction comprises,
a. pre-denaturation at 98 ℃ for 2min
b. Denaturation at 98 ℃ for 10sec
c. Annealing at 58 ℃ for 15sec
d. Extension at 72 ℃ for 5min30sec
b to d repeat 35 cycles
e. Final extension at 72 ℃ for 10 min.
Drawings
FIG. 1 is a diagram showing the result of electrophoresis of a PCR product of a promoter fragment of a zebra fish genomic clone twhh in the present invention;
FIG. 2 is a diagram showing the construction of recombinant plasmid pGEMT-twhh and the result of the rapid enzyme digestion detection of enzyme digestion detection in the present invention;
FIG. 3 is a diagram showing the results of the restriction enzyme detection of the recombinant plasmid pBluescript II-KS-twhh-Dendra2-NTR and the gel electrophoresis of the mass restriction enzyme reaction in the plasmid sequencing;
FIG. 4 is a gel electrophoresis result diagram of the restriction enzyme detection of the recombinant plasmid pBluescript II-KS-twhh-Dendra2-NTR and the rapid restriction enzyme detection in plasmid sequencing;
FIG. 5 is a map schematic of the recombinant plasmid pBluescript II-KS-twhh-Dendra2-NTR prepared based on the sequencing results and known sequence;
FIG. 6 is a diagram showing the development pattern of spinal column of zebra fish obtained in the construction step of transgenic line Tg (twhh: Dendra2-NTR) of zebra fish;
FIG. 7 is a schematic representation of antibody staining of the spinal column cross section of zebra fish;
FIG. 8 is a schematic illustration of a 60dpf zebrafish intervertebral disc and vertebrae;
FIG. 9 is a schematic diagram of a zebrafish intervertebral disc severe injury model obtained in the transgenic line Tg (twhh: Dendra2-NTR) severe injury model construction step;
FIG. 10 is a graphical representation of the results of Micro CT scan analysis of the spine after severe injury to the zebrafish intervertebral discs;
FIG. 11 is a diagram showing the results of testing the effect of no primer on recombinant plasmid construction;
FIG. 12 is a graph showing the results of experiments on the effect of secondary annealing temperature on recombinant plasmid construction.
Detailed Description
The first embodiment is as follows:
the invention relates to a construction method of a zebra fish intervertebral disc injury model, which comprises the following steps:
step one, pBluescriptII-KS-twhh-Dendra2-NTR recombinant plasmid construction
1. Experimental Material
1.1 Experimental animals
The experimental study is carried out in the ecological environment of the three gorges reservoir area in Chongqing city and the national key laboratory breeding base co-constructed with the province of biological resources, and the wild zebra fish (AB line) is bred and raised under the standard experimental conditions according to the regulations of the animal management committee of experiments.
1.2 Experimental reagents
The PCR primer synthesis and sequence determination in this experiment were performed by Shanghai Junjun Biotechnology Co., Ltd;
primer STAR DNA polymerase was from TaKaRa, japan;
l A Taq DNA polymerase was from TaKaRa, Japan;
rTaq DNA polymerase was from TAKARA, Japan;
PCR purification Kit from Qiagen, USA;
t4 DNA L igase enzyme ligase was from Invitrogen, usa;
the DH5 α strain was obtained from Invitrogen, USA.
1.2.1L B liquid Medium preparation:
tryptone (bacto-tryptone),10 g;
5g of yeast extract for bacterial culture (bacto-yeast extract);
sodium chloride (NaCl), 10 g;
adding 950M L distilled water, adjusting pH to 7.0 with 1M NaOH, adding distilled water to 1000ml, diluting the culture medium to constant volume, autoclaving for 20min, cooling, and storing at 4 deg.C.
1.2.2L B solid Medium preparation:
agar powder (agarose),12 g;
tryptone (bacto-tryptone),10 g;
5g of yeast extract for bacterial culture (bacto-yeast extract);
sodium chloride (NaCl), 10 g;
adjusting pH to 7.0 with 1M NaOH, adding distilled water to 1000ml, and autoclaving after completely dissolving; cooled to 55 ℃ and plates were prepared by adding ampicillin (Amp) or kanamycin (Kana) and stored at 4 ℃ after solidification.
1.2.3 microinjection solution
The components and the dosage of the microinjection liquid are shown in the table 1:
TABLE 1
Composition of | Dosage of |
150 ng/. mu. L plasid (plasmid) | 1μL |
10 × I-Sce I buffer | 0.5μL |
I-SceI (restriction endonuclease) | 1μL |
ddH2O (deionized water) | 2.5μL |
Total volume (Total volume) | 5μL |
1.3 Experimental instruments
Zeiss stereodissecting microscope from Zeiss, Germany
Eppendorf gradient PCR instruments from Eppendorf, Germany
Eppendorf tabletop vertical high speed centrifuge is from Eppendorf, Germany.
1.4 related plasmids
The pBluescript-KS-eda-Dendra2-NTR plasmid is from the inventory of the national key laboratory cultivation base of the three gorges reservoir area ecological environment and the province co-construction of biological resources in Chongqing city.
2 method of experiment
2.1 Zebra fish genome extraction
1) 10 zebrafish embryos (3dpf, 3 days post fertilization) were placed per 1.5m L EP tube.
2) 500 μ L L ysis buffer (buffer) +5 μ L proteinase K was prepared, mixed well and added to an EP tube of 1.5m L.
3) Placing 1.5m L EP tube into Thermomixer Comfort (constant temperature mixer), first 55 deg.C, 14h, then 95 deg.C, 30min, and finally storing at-20 deg.C.
2.2 purification of Zebra fish genome
1) RNA free water (RNase-free water) was added to the EP tube of the extracted zebrafish genome to a total volume of 630. mu. L, 70. mu. L sodium acetate was added and mixed well.
2) To step 1) EP tube was added 700. mu. L of PCI (Phenol-Chloroform-Isoamylalcohol ) followed by shaking for homogenization, 13000rcf/min, 15 min.
3) The supernatant was pipetted approximately 600. mu. L into a new EP tube, and then the same volume of isopropanol (isopopanol) was added and mixed well at 4 ℃ 13000rcf/min for 40 min.
4) The supernatant was blotted dry and removed to leave a white precipitate, and 1m L concentration 80% ethanol was added followed by 13000rcf/min at 4 ℃ for 7 min.
5) And (4) repeating the step (4), sucking dry and removing the clean liquid, and placing on ice cubes for drying for about 30 min.
6) DNA was dissolved and concentration was measured by adding 40. mu. L RNA free water, and 2.5. mu. L running gel was sampled to verify the integrity of the DNA.
2.3DNA Polymerase Chain Reaction (PCR)
1) The primer sequences are shown in table 2:
TABLE 2
Primer and method for producing the same | Sequence of |
Forward primer sequence | 5’-GTCGACGTACTGTATCTGTGCTGATTCAC-3’ |
Reverse primer sequence | 5’-GACCAGAAGAGATAATTCAAACGT-3’ |
2) Reaction system for DNA polymerase chain reaction (Primer STAR polymerase)
The components and the amounts of the PCR reaction system are shown in Table 3
TABLE 3
Component (Component) | Volume (dosage) |
Genomic DNA (genome) | 1μL |
Forward primer (10. mu.M) (Forward primer) | 1μL |
Reverse primer (10. mu.M) (Reverse primer) | 1μL |
dNTP (2.5mmol) (deoxynucleoside triphosphate) | |
5 × prime bar buffer | 10μL |
Primer star NEB (polymerase) | 0.5μL |
dd H20 (deionized water) | 32.5μL |
3) Reaction procedure for DNA polymerase chain reaction (Primer STAR polymerase):
the PCR reaction process is shown in Table 4
TABLE 4
4) Twhh promoter agarose gel electrophoresis detection
i. 0.48g of agarose was added to 60m L of 1 × TBE Buffer and placed in a clean flask.
Put the flask into a microwave oven and heat for about 2.5min to dissolve the agarose, destroy the nuclease.
The flask was transferred from the microwave oven, cooled for 3min, and 3 μ L Ethidium Bromide (EB) was added.
And then pouring the completely dissolved glue into a glue groove which is placed into a storehouse at 4 ℃ in advance and cooling for about 15min to fully solidify.
v. add 8. mu. L6 × lodading buffer (loading buffer) to the PCR product of 40. mu. L and mix well.
The mixed PCR product was then spotted into a solidified agarose gel and run at 75V for 40 min.
The correct strip was placed under UV light with a clean blade under gel-cutting into a 1.5m L EP tube and purified for recovery.
5) Recovery and purification of PCR products:
i. the excised gel was weighed, 1mg approximately equal to 1. mu. L, and 200. mu. L/mg of NE buffer (from the PCRdifferentiation Kit purification Kit) was added, heated at 55 ℃ to completely melt the gel strip, and the tube was inverted multiple times during the process to mix the liquid.
And ii, transferring the recovery liquid to a glue recovery and purification column, and centrifuging at the rotating speed of 11000rpm for 1 min.
The filtrate was removed and 750. mu. L NE 3 solution (from PCR purification Kit) was added and centrifuged at 11000rpm for 1 min.
The filtrate was removed and centrifuged again at 11000rpm for 1 min.
v. addition of 20 μ L dd H20 (deionized water) to the gel recovery purification column, standing for 10min, centrifuging at the rotation speed of 11000rpm for 1min, and storing in a refrigerator at-20 ℃.
2.4T vector ligation
The components and amounts of the pGEM-T ligation system are shown in Table 5:
TABLE 5
The corresponding reagents were added according to the PGEM-T ligation reaction system and ligated at 4 ℃ for 14 hours.
2.5 preparation of electrocompetent cells
1) The Escherichia coli DH5 α strain frozen in glycerol was dipped with a sterile toothpick and cultured overnight in 10ml of L B liquid medium at 37 ℃ and 250rpm with shaking.
2) 10ml of the overnight-cultured culture medium was inoculated into a fresh 1L L B liquid medium, cultured with shaking at 37 ℃ and 250rpm for about 2 hours, and the OD600 was measured to be 0.6 to 0.7 (measured every 15 to 20 minutes).
3) Aseptically, the inoculum was transferred to a pre-chilled centrifuge tube and allowed to stand on ice for 30 minutes.
4) Centrifugation was carried out at 5000rpm for 20 minutes at 4 ℃ to discard the supernatant and the bacteria were recovered and resuspended in 1L precooled ultrapure water.
5) Centrifugation was carried out at 5000rpm for 20 minutes at 4 ℃ and the supernatant was discarded, and the bacteria were recovered and resuspended in 100ml of precooled 10% glycerol.
6) Centrifugation was carried out at 6000rpm for 10 minutes at 4 ℃ and the supernatant was discarded, and the bacteria were recovered and resuspended in 20ml of precooled 10% glycerol.
7) Centrifugation was carried out at 6000rpm for 10 minutes at 4 ℃ and the supernatant was discarded, and the bacteria were recovered and resuspended in 2ml of precooled 10% glycerol.
8) And 7, repeating the step.
9) Centrifugation was carried out at 6000rpm for 10 minutes at 4 ℃ and the supernatant was discarded, and the bacteria were recovered and resuspended in 3ml of precooled 10% glycerol.
10) The suspension was dispensed into 1.5ml clean centrifuge tubes (40. mu. L per tube), snap frozen with liquid nitrogen and stored at-80 ℃.
2.6 electroporation competent cell transformation recombinant plasmid
1) And (3) drying the electric rotating cup in a room at 37 ℃ for 20-30 min to ensure that the electric rotating cup is fully dried, and cooling the dried electric rotating cup in ice for 20 min.
2) After thawing the electrocompetent cells obtained in step 2.5 in an ice box, adding 1-2 mu L of the ligation product obtained in step 2.4 into each tube of electrocompetent cells, and then transferring into an electric rotor, wherein the process is light and can not generate bubbles.
3) After the electric transfer, 400. mu. L L B liquid medium was quickly added to the electric rotor and the electric rotor was gently rinsed, and placed in a 37 ℃ room at 250rpm for recovery of culture for 50min while L B solid medium containing Amp (ampicillin) was reversed in the 37 ℃ room and pre-heated to dry.
4) The bacterial liquid after 50min activation is coated on L B solid culture medium containing Amp (ampicillin) preheated and dried in the step 3), and obvious bacterial colonies are obtained after the bacterial liquid is placed in an incubator at 37 ℃ for culturing for 13 h.
2.7 screening and amplification of recombinant plasmids
1) When L B solid culture medium of step 2.6 presents single colony with proper morphology and regular size, the solid culture medium is taken out.
2) A single white colony on L B solid medium was picked using a small sterile pipette tip and inoculated into fresh 5m L L B liquid medium containing 70. mu.g/m L ampicillin (Amp). The culture was carried out overnight (12-14h) at 37 ℃ and 250rpm rotation.
3) Extraction of recombinant plasmid: the plasmid concentration was determined.
2.8 Rapid cleavage reaction to identify recombinant plasmid
The components and the amounts of the rapid enzymatic digestion system are shown in Table 6:
TABLE 6
Component (Component) | Volume (dosage) |
Plasmid (Plasmid)Granule) | 200ng |
10 × Enzyme Buffer | 1μL |
Enzyme(SalI&BamHI) (restriction enzyme) | 0.2μL |
dd H2O (deionized water) | Variable |
Totoal (Total volume) | 10μL |
Adding corresponding reagents into an EP tube according to a system shown in Table 7, generally placing the tube at the optimal enzyme reaction temperature of 37 ℃ for enzyme digestion for 30min, carrying out gel electrophoresis detection by using agarose with the concentration of 1%, determining a recombinant plasmid with the correct enzyme digestion result, and sending the recombinant plasmid to the Shanghai Yingjun biotechnology limited company for identification.
2.9 bulk digestion and recovery of the corresponding target fragment of the recombinant plasmid
An appropriate restriction site (SalI & BamHI) was selected based on the map of the laboratory stock plasmid pBluescript-KS-ela-Dendra2-NTR, the plasmid pBluescript-KS-ela-Dendra2-NTR after restriction retains about 4kb of backbone, and the plasmid pGEMT-twhh takes about 4kb of fragment after restriction as an insertion sequence.
1) The composition and amounts of the bulk digestion system are shown in Table 7:
TABLE 7
Component (Component) | Volume (dosage) |
Plasmid (Plasmid) | 8μg |
Cutsmart (buffer) | 10μL |
Enzyme(SalI&BamHI) (restriction enzyme) | 2μL |
dd H2O (deionized water) | Variable |
Totoal (Total) | 100μL |
Corresponding reagents are added to a new EP tube according to the above system, and the enzyme digestion is carried out for 2-3 hours at 37 ℃ or other suitable temperatures. And (3) recovering and purifying an enzyme digestion product: the same procedure as for recovery and purification of PCR products. The plasmid pBluescript-KS-ela-Dendra2-NTR and the plasmid pGEMT-twhh were digested with restriction enzymes (SalI & BamHI) and recovered and purified to obtain 4kb pBluescript-KS-Dendra2-NTR fragment and 5.8kb twhh promoter fragment, respectively, for subsequent use in subsequent T4 DNA ligation enzyme (T4 ligase) ligation experiments.
2) T4 DNA ligation enzyme (T4 ligase)
The components and amounts of the T4 ligation enzyme (T4 ligase) ligation system are shown in Table 8:
TABLE 8
Component (Component) | Volume (dosage) |
T4 ligation enzyme | 3.5μL |
twhh promoter fragment | 2.5μL |
pBluescript-KS-Dendra2-NTR fragment | 1μL |
Ligation was carried out at 4 ℃ for 13 h. The transformation and screening were carried out in sequence according to the above system, and the recombinant plasmid pBluescript-twhh-Dendra2-NTR was identified by rapid digestion (ApaI & NcoI) and analyzed by Shanghai Invitrogen Biotech Ltd.
2.10 purification of recombinant plasmids
1) RNase Free Water (RNase-Free Water) was added to the recombinant plasmid pBluescript-twhh-Dendra2-NTR to 630. mu. L, and after mixing, 70. mu. L sodium acetate (NaAc) was added and mixed by shaking.
2) 700 μ L PCI (Phenol-Chloroform-Isoamylalcohol ) was added, shaken for 30 seconds, 13000rpm, and centrifuged for 20 min.
3) Pipette 650. mu. L supernatant into a new EP tube, add 650. mu. L isopropanol, shake for 10 seconds, 11000rpm, centrifuge for 20 min.
4) The supernatant in the EP tube was removed, and the white precipitate of the residual DNA was centrifuged for 7min with 75% ethanol 1m L at 13000 rpm.
5) Remove the alcohol, left to dry on ice, add 40 u L nucleic free water (Nuclease free water) dissolved, detection of plasmid concentration and OD value.
3 results
3.1 cloning of the promoter fragment of twhh from the Zebra Fish genome
A pBluescript-twhh-Dendra2-NTR recombinant plasmid was constructed by PCR amplification of the promoter sequence of the 5.8kb twhh (tiggy-winkle Hedgehog, a member of the Hedgehog family) gene from the zebrafish genome. A BamHI site is added into the forward primer, and a SalI site is added into the reverse primer, so that the subsequent experiment can be conveniently carried out. As shown in FIG. 1, the PCR products were spotted, the results of gel electrophoresis showed that the brightest band in lane 1 was between 5000 and 6000bp, the 5.8kb gel target band containing the twhh promoter was excised and recovered under an ultraviolet lamp and purified, and the position of the nonspecific band was shown to be about 1100bp (the excision of the gel target band without affecting the twhh promoter and the recovery and purification of the gel target band). Lane 2 is 1Kb DNAmarker, and lane 1 is the twhh promoter fragment.
3.2 construction and enzyme digestion detection of recombinant plasmid pGEMT-twhh
Ligation of purified PCR amplification productsT Easy Vector, transformed with electrotransformation peptide DH5a, and extracted by screening with blue-white spots to pick out ampicillin resistant white spots and amplify positive colonies, and the correct pGEMT-twhh recombinant plasmid was excised with BamHI and SalI enzymes to form bands of 3015bp and 5784 bp. As shown in fig. 2, the rapid enzyme digestion assay showed: lane 1 shows the false positive plasmid pGEMT-twhh, lane 2 shows the correct recombinant plasmid pGEMT-twhh, and lane 3 shows the band of 1kb DNA marker. Lane 3 is 1Kb DNA marker, and lanes 1 and 2 are the recombinant plasmid pGEMT-twhh to be tested.
3.3 restriction enzyme digestion detection and plasmid sequencing of recombinant plasmid pBluescript II-KS-twhh-Dendra2-NTR
The plasmid pGEMT-twhh and the plasmid pBluescript-KS ela-CFP-NTR were digested in large quantities with BamHI restriction enzyme and SalI restriction enzyme, the insertion sequence of the twhh promoter (5.8kbp) and the fragment of pBluescript-KS vector (4.8kb) were recovered from the gel, and the gel band of the desired fragment was excised, recovered and purified.
The results of gel electrophoresis for a number of enzyme digestion reactions are shown in FIG. 3: lane 1 is a 1kb DNA marker band. The plasmid in lane 2 is pGEMT-twhh, 5.8kb fragment as insert. The plasmid in lane 3 is pBluescript-KS-ela-Dendra2-NTR plasmid, 4.8kb of the digested fragment is taken as a vector fragment, the gel is cut, the corresponding fragment is recovered, the vector fragment is connected by T4 DNA ligase, electrotransformation peptide DH5a is used for transformation, and a single colony with ampicillin resistance is screened out and subjected to amplification culture to extract a correct recombinant plasmid. The correct pBluescript-KS-twhh-Dendra2-NTR recombinant plasmid was digested with the restriction enzyme ApaI to obtain 6082bp and 4150bp bands, and with NcoI to obtain 7230bp and 3002bp bands. The results of gel electrophoresis of the rapid cleavage assay are shown in FIG. 4: wherein lanes 1 and 4 are the recombinant plasmid No. 1 to be detected, lanes 2 and 5 are the recombinant plasmid No. 2 to be detected, and the gel electrophoresis images are cut by restriction enzymes ApaI and NcoI respectively. And (3) respectively applying restriction enzymes ApaI and NcoI to carry out rapid enzyme digestion detection: lane 1 is the band 6082bp and 4150bp of the recombinant plasmid No. 1 to be detected after digestion with the restriction enzyme ApaI, lane 2 is the band 1700bp and 7000bp of the recombinant plasmid No. 1 to be detected after digestion with the restriction enzyme ApaI, lane 3 is the band display region of the 1kb DNA marker, lane 4 is the band 7230bp and 3002bp of the recombinant plasmid No. 2 to be detected after digestion with the restriction enzyme NcoI, lane 5 is the band 2000bp and 6000bp of the recombinant plasmid No. 2 to be detected after digestion with the restriction enzyme NcoI, lanes 1 and 4 are the correct recombinant plasmid pBluescript-KS-twhh-Dendra2-NTR, and lanes 2 and 5 are the false positive recombinant plasmid pBluescript-KS-twhh-Dendra 2-NTR.
We sent the recombinant plasmid pBluescript II-KS-twhh-Dendra2-NTR with correct enzyme digestion detection to the Nengjun Biotechnology Limited company in the Shanghai for sequencing, and the sequencing result shows that the twhh promoter is correctly connected to the pBluescript II-KS-I-Dendra2-NTR vector fragment, which indicates that we have successfully constructed the recombinant plasmid pBluescript II-KS-twhh-Dendra 2-NTR.
3.4 sequencing results of the recombinant plasmid pBluescript II-KS-twhh-Dendra2-NTR
The primary correct recombinant plasmid pBluescript II-KS-twhhh-Dendra 2-NTR is sent to Shanghai Yingjun Biotechnology Limited company for sequencing, and the sequencing result shows that the twhh promoter is correctly connected with the pBluescript II-KS-I-Dendra2-NTR vector fragment, and the plasmid pBluescript II-KS-twhhh-Dendra 2-NTR is successfully constructed, and as shown in figure 5, the plasmid pBluescript II-KS-twhhh-Dendra 2-NTR map is made according to the sequencing result and the known sequence.
Step two, constructing the transgenic line Tg (twhh: Dendra2-NTR) of the zebra fish
1. Experimental Material
1.1 Experimental animals
The experimental study is carried out in the ecological environment of the three gorges reservoir area in Chongqing city and the national key laboratory breeding base co-constructed with the province of biological resources, and the wild zebra fish (AB line) is bred and raised under the standard experimental conditions according to the regulations of the animal management committee of experiments.
1.2 Experimental reagents
DMSO (dimethyl sulfoxide) is from Shanghai Biotechnology company, China
Mtz (Metronidazole) from Sigma;
PTU (1-phenyl-2-thiourea) was obtained from Sigma;
tricaine (ethyl m-aminobenzoate) was from Sigma company;
PT (buffered solution) PBS (phosphate buffered saline) + 1% Triton X-100 (polyethylene glycol octylphenyl ether);
PBTN (blocking solution) PT + 4% BSA (bovine serum albumin) + 0.02% NaN3 (sodium azide).
1.3 microinjection
The compositions and amounts of the microinjection solutions are shown in Table 9
Table 9 (recombinant plasmid pBluescriptII-KS-twhh-Dendra2-NTR from results 3.4)
Component (Component) | Volume (dosage) |
Recombinant plasmid (150 ng/. mu. L) | 1μL |
10 × I-SceI buffer (buffer) | 0.5μL |
I-SceI (Endonuclease) | 1μL |
ddH2O (deionized water) | 2.5μL |
2. Laboratory apparatus
A Peking love zebra fish culture system;
l SM780 laser confocal microscope (Zeiss, Germany)
Zeiss AxioImageZ1 full-automatic upright fluorescence microscope (Zeiss, Germany)
Zeiss SteREO discovery V20 fluorescent stereomicroscope (Zeiss, Germany)
L Eica stereomicroscope (L Eica, Germany)
L eica M165C fluoroscope microscope (L eica, Germany).
3. Related plasmids
pBluescript-KS-twhh-Dendra2-NTR plasmid from the first step results.
4. Experimental methods
4.1 microinjection of embryos
4.1.1 preparation work
1) An injection tank, 1.5g agarose to 100ml egg water is weighed and added into a flask, the flask is heated in a microwave oven for 3min, the flask is taken out, the flask is placed on a table and poured into a culture dish, about 30m L gel liquid is taken out, a clean mold is taken, one end of the mold is firstly contacted with the liquid surface and is slowly covered until the whole template is stably floated above the liquid surface, the mold is taken out after the gel liquid is solidified, a small amount of egg water is poured into the culture dish, the whole injection tank is just covered, and the mold is stored at 4 ℃.
2) Needle pulling: the sterile thin glass tube is fixed to a needle drawing instrument, and the microsyringe to be used is drawn out instantly. The heating position should be located in the middle of the capillary glass tube as much as possible during the process, so that the two drawn needles have moderate length and uniform thickness. The most forward end of the needle was cut with a clean blade under a stereomicroscope.
3) Preparing zebra fish to be mated: before and after injection, 10 pairs of adult fish with large fish body and obvious body color can be selected. They were placed in pairs in a distribution tank, with baffles in between, and separated overnight. The baffles can be taken out to mate seven moments in the morning the next day.
4.1.2 microinjection work on the day
1) Preparing injection, namely preparing the injection at present, sucking 3 mu L by using a pipette gun, injecting the injection into a prepared pull needle, fixing the needle on a microinjection instrument, and adjusting the position of the injection needle to be suitable for microinjection.
2) Mating and embryo collection: the baffle in the aquarium is extracted to allow the male zebra fish to catch up with the female zebra fish to stimulate spawning. After spawning, wait 10min when the embryo has been fully fertilized and developed to the stage best suited for injection. Embryos were collected with egg water for use.
3) And (3) injection: selecting young fish embryo in the oval single cell period. The embryo yolk is slightly pressed into the injection groove by pointing the embryo yolk towards the direction of needle injection with a metal poking needle. 0.15ng of the injection solution was injected into each embryo, and the injected embryos were placed in a new petri dish, soaked with egg water, and cultured in an incubator at 28.5 ℃.
4.1.3 selection and passage stabilization of transgenic Fish lines
Culturing the injected embryo to the third day, observing that the reporter gene twhh (tiggy-winklehedgehog, a member of Hedgehog family) has green fluorescence expression in the notochord region under a fluorescence microscope, and selecting juvenile fish with strong fluorescence signal for continuous culture. And (3) hybridizing adult fish with strong fluorescence signals with wild zebra fish (AB line) for passage until the intensity of the fluorescence signals is stable, and generally hybridizing the adult fish with strong fluorescence signals with the wild zebra fish for three generations to obtain a stable transgenic fish line.
4.1.4 antibody development
The first day:
1) zebra fish transgenic line Tg (twhh: Dendra2-NTR) samples were collected for appropriate periods (25dpf, 45dpf, 60dpf), material was fixed with 4% PFA (paraformaldehyde), and embryos were rinsed 3 times for 5min each with 1ml of PT solution.
2) Embryos were rinsed 2 times for 5min with 1ml PBS (phosphate buffered saline).
3) 1ml of 4% paraformaldehyde was added and fixed overnight at 4 ℃ (12-14 h).
The next day:
1) embryos were rinsed 3 times for 5min with PBS (phosphate buffered saline).
2) Blocking was carried out with PBTN (blocking solution) at 4 ℃ for 2 hours.
3) Primary antibody (e.g.anti-dendra 2) is added and the mixture is diluted with PBTN (blocking solution) in a ratio of 1:1000 and incubated overnight at 4 ℃.
And on the third day:
1) the antibody was recovered and was able to be reused 3 times.
2) Embryos were rinsed 5 times 45min each with PT (buffer).
3) Add secondary antibody Goat-anti-rabbit488 (Green fluorescence) secondary antibody was diluted with PBTN (blocking solution) at a ratio of 1:500 to 1:1000, 200ul per tube. Incubate at room temperature for 2 hours, or at 4 ℃ overnight (usually overnight). The incubation was protected from light (wrapped in tinfoil) to avoid quenching the fluorescence.
The fourth day:
1) the secondary antibody was removed and the embryos were rinsed 5 times for 45min each with PT (buffer).
2) lmlPT +0.2ul DAPI (4', 6-diamidino-2-phenylindole, DAPI reagent stored at-30 deg.C, taken out and placed on an ice box to melt for about 15min, and taken out of the dark place) was added to a new EP tube, and the horizontal shaker was shaken uniformly for one hour. Embryos were transferred to PT (buffer) containing 80% glycerol for observation under a microscope.
3) The samples can be stored in PT solution at 4 ℃ in the dark and photographed.
5. Results of the experiment
5.1 expression Pattern of the transgenic Zebra Fish line Tg (twhh: Dendra2-NTR)
The development process of the spinal column of the zebra fish is revealed by scanning with a confocal laser microscope (Zeiss L SM780), as shown in figure 6, when the young fish develops to 12dpf, the intensity of green fluorescence of the spinal cord and the base plate of the zebra fish (namely, the area indicated by a straight arrow in figure 6 shows a gray area) gradually weakens, alizarin red staining (namely, the area indicated by a curved arrow in figure 6, namely, the area which shows gray color in the rest parts except a rectangular frame) shows that the vertebrae mineralizes in a ring shape, the mineralization of the vertebrae is gradual from the head to the tail of the spinal cord, the spinal cord is mainly occupied by vacuolar spinal cord cells marked by green fluorescence, at 17dpf, the spinal cord and the base plate of the zebra fish are marked by green fluorescence, the fluorescence expression intensity of the head is consistent with that of the tail, the mineralization of the vertebrae shown by the alizarin red staining starts to expand and develop towards the front end and back abdominal side, and at 25dpf, a large amount of green fluorescence cells gather towards the spinal area of the spinal column, the intervertebral area is obviously stronger than the green fluorescence intensity of the spinal area, each vertebral body is shown by the spinal cord, and the anterior side of the spinal cord and the vertebral body is shown by the three spinal cord, and the three spinal.
5.2 expression characteristics of intervertebral disc-specific marker Gene twhh in intervertebral discs
The expression characteristics of the twhh gene in the intervertebral disc at different periods of the spinal column development of the zebra fish are revealed by staining antibodies to the spinal column cross section of the zebra fish. As shown in fig. 7: at 25dpf, cells with green-stained fluorescence (i.e., the area indicated by the straight arrow in FIG. 7 showing grayish white color) were mostly localized to the notochordal sheath wall, and cells with green fluorescence labeled with the twhh gene were vacuolated notochordal cells. When the juvenile fish develops to 45dpf, the green fluorescent cells are only expressed in the intervertebral disc tissues, the outer-layer annulus fibrosus cells and the inner-side nucleus pulposus cells are both marked by the green fluorescent signals, and at the moment, the twhh gene is simultaneously expressed in the outer-layer annulus fibrosus cells and the inner-side nucleus pulposus cells of the intervertebral disc. At 60dpf, green fluorescent cells were only expressed in the annulus fibrosus cells of the outer layer of the disc tissue, and no expression of green fluorescent signal was found in the nucleus pulposus cells of the inner side, at which time the twhh gene green-stained fluorescent cells were only expressed in the annulus fibrosus cells of the disc and no longer labeled nucleus pulposus cells. As shown in fig. 8, when the juvenile fish developed to 60dpf, green fluorescent cells (white areas indicated by the straight line arrows in fig. 8) appeared highly expressed in the disc tissues, alizarin red staining (white areas indicated by the curved arrows in fig. 8) showed that the vertebrae developed completely maturely, and the green-labeled intervertebral discs were embedded inside the red-labeled vertebrae, as shown by cross-sectional antibody staining: at 60dpf, the green stained fluorescent cells were expressed only in the annulus fibrosus cells of the disc and no longer labeled nucleus pulposus cells. Through repeated continuous microinjection of recombinant plasmids, we screened the Founders whose expression site has strong fluorescent expression and can be stably inherited in the offspring for subsequent experiments. The transgenic line Tg (twhh: Dendra2-NTR) juvenile fish used in the experiments performed subsequently were all stably inherited offspring from transgenic fish lines with consistent levels of fluorescent expression of intervertebral disc cells of various segments of the spinal column.
Degeneration of vertebrae caused by severe damage of intervertebral discs
In the experiment, the Mtz/NTR system is used for simulating intervertebral disc degeneration of the stable zebra fish transgenic fish line Tg (twhh: Dendra2-NTR) in the early-stage experiment, and the intervertebral disc degeneration caused by the intervertebral disc degeneration of the intervertebral disc severe damage is found through laser confocal scanning. Continuous and accurate scanning of Micro CT in a three-dimensional direction can be used for generating high-resolution scanning data to analyze phenotypes such as vertebra biomineralization abnormality and the like.
Step three: construction of transgenic line Tg (twhh: Dendra2-NTR) severe injury model
1. Experimental Material
1.1 Experimental animals
The experimental study is carried out in the ecological environment of the three gorges reservoir area in Chongqing and the national key laboratory breeding base of province co-construction of biological resources, and the zebra fish transgenic line Tg (twhh: dendro 2-NTR) is propagated and raised under the standard experimental conditions according to the regulations of the animal management committee.
1.2 Experimental reagents
DMSO (dimethyl sulfoxide) was from shanghai bio-technology;
mtz (Metronidazole) from Sigma;
PTU (dianilinemethylthioketone) from Sigma company;
tricaine (ethyl m-aminobenzoate) was obtained from Sigma company.
1.2.1 Mtz (Metronidazole) treatment Agents
1) Treatment group solution: mtz (metronidazole) powder of the corresponding weight was weighed, added to eggwater (egg water) containing 0.2% DMSO, placed on a horizontal shaker in a room at 37 ℃ and shaken at 250rpm for 2h to dissolve, and then, strictly protected from light.
2) Control group solution: 0.2% DMSO was added to egg water and placed on a 37 ℃ room horizontal shaker at 250rpm to dissolve for 2h, protected from light.
1.3 Experimental instruments
A Peking love zebra fish culture system;
l SM780 confocal laser microscope from Zeiss, Germany;
heraeus vertical constant temperature embryo incubator;
zeiss SteREO discovery v20 fluoroscope microscope;
l eica stereodissection microscope;
l Eica M165C fluoroscope.
2. Experimental methods
1) 60 days after fertilization was selected as the starting time for juvenile fish treatment.
2) Mtz (Nitrocellum file) solution with a concentration of 10mM and a control solution are prepared, and the juvenile fish are soaked in the dark for 72 hours.
3) And observing the change of the fluorescence of the juvenile fish in the treatment group and the control group by using a body type fluorescence microscope. The young fish intervertebral disc cells in the treatment group were waited for the complete disappearance of the green fluorescence signal and washed with fresh egg water.
4) The optimal Mtz solution treatment concentration, starting time and duration are determined according to the treatment condition of the juvenile fish.
3. Results of the experiment
As shown in FIG. 9, the treated group was 10mM Mtz solution, the control group was 0.2% DMSO solution, 60dpf of the Tg (twhh: Dendra2-NTR) of the young transgenic fish was selected and subjected to the experiment, when the treated group was treated with Mtz (metronidazole) solution in the dark for 72 hours, the intensity of green fluorescence (white area indicated by the straight arrow in FIG. 9) of the young fish of the treated group was significantly reduced until disappearance, scanning with a confocal laser microscope (Zeiss L SM780) revealed that the young fish recovered for 0 days after treatment with Mtz (metronidazole) and the green fluorescence cells of the fibrous ring of the young fish of the control group were present in large quantity, and the central part of the red vertebrae located outside the white area indicated by the straight arrow, which showed gray intervertebral disc, had well-aligned segmental arrangement, whereas the green fluorescence cells of the fibrous ring of the treated group young fish were completely disappeared, and the width of the green fluorescence cells of the spinal ring of the treated group was not lost, and the spinal disc had been closely connected with Mtz, and the width of the spinal disc between the spinal discs remained well-aligned, and the red fluorescence of the control group had significantly decreased, and the spinal disc, had not appeared, but the spinal disc, had remained well-aligned segmental arrangement, and the control group had appeared, when the spinal disc, had been treated group, had been closely-stained, had.
Step four: micro CT scanning analysis of spine after severe injury of zebra fish intervertebral disc
1. Experimental Material
1.1 Experimental animals
The experimental animals were the same as in step three.
1.2 Experimental reagents
The experimental reagent is the same as in step three.
1.3 Experimental instruments
A Peking love zebra fish culture system;
Micro-CT is from vivaCT40, Switzerland SCANCO.
2. Experimental methods
Zebrafish samples from control and treated groups recovered for 0 days (R0D) after Mtz treatment and 40 days (R40D) after Mtz treatment were fixed with 4% PFA (paraformaldehyde) by first scanning the entire fish spine (resolution of 17 μm) and then isolating the tail spine of the entire fish under a stereomicroscope as a local precision scan fraction (resolution of 10 μm). The scanning voltage is set to 70KV, and the current is set to 500 mA.
3. Results of the experiment
As shown in the rectangular box of fig. 10: mtz recovery day 0 after treatment (R0D), the vertebrae in the control group were aligned in segments, whereas the vertebrae in the treated group were closely connected and the intervertebral space was apparently covered by abnormally mineralized bone tissue in the intervertebral area. Mtz (Metronidazole) is recovered for 40 days (R40D), the mineralization of the vertebra of the young fish of the control group is obviously enhanced, however, the vertebra of the young fish of the treatment group is more closely connected, the mineralization of the intervertebral area is obviously enhanced, so that the intervertebral space is completely disappeared, the biomineralization abnormality of the vertebra causes the morphological abnormality of the single vertebra, and the obvious shortening of the length of the single vertebra is the main reason for shortening the length of the whole fish spine.
Therefore, the transgenic line Tg (twhh: Dendra2-NTR) in the construction method of the invention explains the development process of the intervertebral disc and vertebra of the zebra fish in detail, and shows that the twhh gene promoter can drive the expression of green fluorescent protein, thereby clearly recording the gradual conversion process of the zebra fish from the development of notochord cells to the development and maturation of intervertebral disc cells. A specific intervertebral disc injury model is constructed based on an Mtz/NTR system, and Nitroreductase (NTR) is specifically expressed by cells mainly through a recombinant transgenic line successfully constructed in the early stage. The basic principle of the zebra fish intervertebral disc injury is as follows: disc cells expressing nitroreductase are killed by Nitroreductase (NTR) in combination with metronidazole (Mtz). The current research suggests that: degeneration of the intervertebral disc is one of the most prominent pathological processes leading to lower back pain and is a prerequisite for herniated intervertebral discs. Although mechanical stress is a very important regulatory factor leading to disc degeneration, the underlying molecular mechanisms for disc degeneration remain unknown. By combining the advantages of the zebra fish living in water, the influence of long-term mechanical pressure of external gravity on the zebra fish intervertebral disc stimulation can be eliminated. Compared with a mouse intervertebral disc degeneration model which mainly aims at damaging a plurality of local intervertebral discs of the lumbar vertebra of a mouse in a fixed point mode through a surgical operation mode, the invention specifically damages all the intervertebral discs in a zebra fish body in a mode of soaking a zebra fish transgenic line Tg (twhh: Dendra2-NTR) by a metronidazole medicament, and constructs a novel animal model of all the intervertebral discs in the zebra fish body by means of severe damage of all the intervertebral discs in the zebra fish body.
In the experiment, 10mM Mtz (metronidazole) solution is used as a treatment group, 0.2% DMSO is used as a control group, and the treatment is carried out for 72 hours under the condition of keeping out of the sun, wherein the green fluorescence of the intervertebral disc of the transgenic line Tg (twhh: Dendra2-NTR) of the control group is not obviously changed, but the green fluorescence of the whole intervertebral disc of the juvenile fish of the treatment group obviously disappears. This indicates that Mtz (metronidazole) in the treatment group was able to induce the production of NTR (nitroreductase) lethal protein, the Mtz/NTR (metronidazole/nitroreductase) system was able to specifically cause the death of NTR (nitroreductase) -expressing cells, whereas DMSO in the control group had no effect on disc development. Therefore, the construction method of the Tg (twhh: Dendra2-NTR) transgenic zebra fish intervertebral disc injury model constructed by the inventor is successful.
When we soaked young fish with metronidazole MTZ drug, the green fluorescent cells on the annulus fibrosus in the disc would exert corresponding cytotoxicity, we distinguished the degree of disc injury by the time of metronidazole MTZ drug soaking at 10mM L working concentration, treated continuously for 72 hours by light-shielding soaking, thereby the phenomenon of massive apoptosis on the annulus fibrosus occurs, while metronidazole MTZ would not damage other tissues around, mouse model of disc degeneration is often used to explore the effect of mechanical pressure in disc degeneration, induced apoptosis of the annulus fibrosus by mechanical overload for 24 hours and resulted in some disc degeneration in mice, revealed by immunostaining that cytochrome C is released but no apoptosis-related factor ligand is generated, Rannou et al, by collecting human samples, analysis of mouse model, combined with disc culture experiment, proved that mechanical overload induced disc degeneration is regulated by apoptosis pathway in disc cells, however, we discovered that Mtz/NTR system specific damaged disc cells, induced disc degeneration is convenient for developing intervertebral disc degeneration, thus, we further discovered whether there is a serious defect that the degeneration of intervertebral disc is caused by the degeneration of intervertebral disc, which we are disturbed spinal bone degeneration caused by the abnormal bone degeneration of some intervertebral disc, and the abnormal bone degeneration of mare.
The transgenic line Tg (twhh: Dendra2-NTR) has seriously damaged intervertebral discs to cause vertebral body degeneration, the intervertebral discs are specifically marked by green fluorescent protein, and mineralized vertebrae are specifically marked by alizarin red staining, and under the standard experimental conditions, the severely damaged intervertebral discs can not be recovered by self and cause serious defects of development and mineralization of the vertebrae. Two transgenic fish lines of Tg (twist: EGFP) and Tg (osteopocalcin: GFP) are constructed in connection with Inohaya et al to mark precursor osteoblasts and mature osteoblasts of the vertebral body respectively, and the differentiation of green fluorescent precursor osteoblasts in the intervertebral area into red fluorescent mature osteoblasts of the vertebral body is verified by scanning through a laser confocal microscope by using the double transgenic fish line. This study considered that: the precursor osteoblasts derived from the osteogenic segments in the intervertebral region of the spine differentiate into mature osteoblasts of the vertebral body, which serves as a growth center during growth and development of the vertebral body. Combining the research results, we preliminarily speculate that the zebra fish intervertebral disc plays an important role in the growth and development of vertebrae.
The experimental technical means prove that the zebra fish intervertebral disc severe injury model can be used for researching an intervertebral disc degeneration model, and then the intervertebral disc degeneration of zebra fish causes degenerative change of vertebrae, which shows that the animal model constructed by the method can be used for exploring related molecular regulation and control mechanisms of intervertebral disc degeneration and vertebra degeneration. The action mechanism is preliminarily presumed that the severely damaged intervertebral disc can not restore to generate degenerative changes, the microenvironment of the intervertebral area of the spine is influenced, and the stable equilibrium of the vertebrae is disordered, so that the pathological phenotype of the vertebrae degeneration is generated.
Test one: effect of primer-free construction of recombinant plasmids
The test method comprises the following steps: the difference is that the following steps are consistent with the operation method of the first step in the embodiment: DNA Polymerase Chain Reaction (PCR) four different primer sequences were set up as shown in table 10:
watch 10
Forward primer FW | Reverse | |
Lane | ||
1 | | gtccttgcaccatttgtctgtc |
Lane | ||
2 | | gacgtttgaattatctcttctggtc |
Lane | ||
4 | | gtccttgcaccatttgtctgtc |
Lane | ||
5 | gtactgtatctgtgctgattcac | gacgtttgaattatctcttctggtc |
The test results are shown in fig. 11:
it can be seen from this that: lane 3 is a 1kb DNA marker. Lane 5 has a specific 5.8kb twhh fragment, and is more intense, indicating a higher concentration, and can be used for construction of pGEMT-twhh recombinant plasmids. Lanes 1,2 and 4 show a specific 5.8kb twhh fragment, and the intensity was modest, and the non-specific band was too much dragged to construct pGEMT-twhh recombinant plasmid.
And (2) test II: effect of annealing temperature on recombinant plasmid construction
The test method comprises the following steps: the method is consistent with the first step operation method of the embodiment, and the difference is that: DNA Polymerase Chain Reaction (PCR) two different annealing temperatures were set as shown in table 11:
TABLE 11
PCR reaction system and reaction process of | |
Lane | |
1 | The annealing temperature is 58 |
Lane | |
3 | The annealing temperature is 52 DEG C |
The test results are shown in fig. 12:
it can be seen from this that: lane 2 is a 1kb DNA marker. Lane 1 shows a specific 5.8kb twhh fragment and some non-specific bands, but the 5.8kb twhh fragment is very bright, indicating that the concentration is high, and is beneficial to the construction of pGEMT-twhh recombinant plasmid. Lane 3 shows no specific 5.8kb twhh fragment and is not useful for construction of pGEMT-twhh recombinant plasmids.
It will be apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the invention, which should not be construed as affecting the effect of the invention and its practical application.
<110> Chongqing college of medical sciences affiliated oral hospital
Construction method of <120> zebra fish intervertebral disc injury model
<160>10
<210>1
<211>29
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>1
GTCGACGTACTGTATCTGTGCTGATTCAC
<210>2
<211>24
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>2
GACCAGAAGAGATAATTCAAACGT
<210>3
<211>22
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>3
cgtccatgtgtaactccgtaac
<210>4
<211>22
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>4
gtccttgcaccatttgtctgtc
<210>5
<211>22
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>5
cgtccatgtgtaactccgtaac
<210>6
<211>25
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>6
gacgtttgaattatctcttctggtc
<210>7
<211>23
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>7
gtactgtatctgtgctgattcac
<210>8
<211>22
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>8
gtccttgcaccatttgtctgtc
<210>9
<211>23
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>9
gtactgtatctgtgctgattcac
<210>10
<211>25
<212>RNA
<213> Artificial sequence
<220>
<221>prim_bind
<400>10
gacgtttgaattatctcttctggtc
Claims (3)
1. The construction method of the zebra fish intervertebral disc injury model comprises a DNA polymerase chain reaction, and is characterized in that primers and sequences used in the DNA polymerase chain reaction are as follows:
a forward primer: 5'-GCGTCGACGTACTGTATCTGTGCTGATTCAC-3'
Reverse primer: 5'-CGGGATCCGACGTTTGAATTATCTCTTCTGGTC-3'
Extracting genome DNA from a zebra fish embryo which is fertilized for 3 days, and then obtaining a promoter fragment of a twhh gene through a DNA polymerase chain reaction, wherein the zebra fish germ line is a wild zebra fish AB germ line;
also comprises an expression vector construction step, a transgenic step and a metronidazole treatment step;
in the construction step of the expression vector, the promoter fragment of the twhh gene is connected to a plasmid vector containing a Dendra2-NTR gene to obtain the expression vector; the promoter fragment of the twhh gene is used for starting the expression of the Dendra2-NTR gene;
in the transgenic step, the expression vector is injected into a zebra fish embryo, and a stable transgenic fish line is obtained through multi-generation hybridization;
in the metronidazole treatment step, transgenic young fish 60 days after fertilization is treated with 10mM metronidazole for 72h, and a zebrafish intervertebral disc injury model is obtained.
3. the method for constructing the zebrafish intervertebral disc injury model according to claim 1 or 2, wherein: the reaction process of the DNA polymerase chain reaction is,
a. pre-denaturation at 98 ℃ for 2min
b. Denaturation at 98 ℃ for 10sec
c. Annealing at 58 ℃ for 15sec
d. Extension at 72 ℃ for 5min30sec
b to d repeat 35 cycles
e. Final extension at 72 ℃ for 10 min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710074948.5A CN106868043B (en) | 2017-02-08 | 2017-02-08 | Method for constructing zebra fish intervertebral disc injury model |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710074948.5A CN106868043B (en) | 2017-02-08 | 2017-02-08 | Method for constructing zebra fish intervertebral disc injury model |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106868043A CN106868043A (en) | 2017-06-20 |
CN106868043B true CN106868043B (en) | 2020-08-04 |
Family
ID=59167083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710074948.5A Active CN106868043B (en) | 2017-02-08 | 2017-02-08 | Method for constructing zebra fish intervertebral disc injury model |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106868043B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111308030B (en) * | 2020-03-22 | 2022-04-29 | 杭州环特生物科技股份有限公司 | Method for evaluating sleep improvement effect of dairy product by using zebra fish |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104981150A (en) * | 2012-12-06 | 2015-10-14 | 马克思-普朗克科学促进协会 | Novel inducible animal models of stress behavior |
-
2017
- 2017-02-08 CN CN201710074948.5A patent/CN106868043B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104981150A (en) * | 2012-12-06 | 2015-10-14 | 马克思-普朗克科学促进协会 | Novel inducible animal models of stress behavior |
Non-Patent Citations (2)
Title |
---|
"Danio rerio tiggy-winkle hedgehog (twhh), complete cds";Ekker,S.C等;《GenBank DataBase》;19960130;Accession No. U30710.1 * |
"Zebrafish tiggy‐winkle hedgehog promoter directs notochord and floor plate green fluorescence protein expression in transgenic zebrafish embryos";Shao Jun Du等;《Developmental Dynamics》;20011109;摘要,第656页左栏最后1段和右栏,第661页左栏第1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN106868043A (en) | 2017-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Oda et al. | Dynamics of Arabidopsis SUN proteins during mitosis and their involvement in nuclear shaping | |
CN107109434A (en) | Novel CHO integration sites and its purposes | |
CN110337493A (en) | For treating the composition and method of myotonia atrophica | |
CN109224130A (en) | Long-chain non-coding RNA lnc-HCAR is preparing application and Bone Defect Repari system and preparation method in Bone Defect Repari system | |
CN110484549A (en) | Genome targeting modification method | |
CN106086031A (en) | Pig flesh chalone gene editing site and application thereof | |
CN109996873A (en) | Transplanting cell mass and its manufacturing method | |
CN106868043B (en) | Method for constructing zebra fish intervertebral disc injury model | |
CN102041316A (en) | Application of micro ribonucleic acid (miRNA)-219 compound as marker of brain glioma | |
Kontarakis et al. | Transgenesis in non-model organisms: the case of Parhyale | |
US20200149063A1 (en) | Methods for gender determination and selection of avian embryos in unhatched eggs | |
KR102588627B1 (en) | Composition for preparing extracellular matrix using MAST4 gene and method for preparing the same | |
Portnoy et al. | Detection of potential GDF6 regulatory elements by multispecies sequence comparisons and identification of a skeletal joint enhancer | |
CN108660112A (en) | A kind of cultural method of mesenchymal stem cell and transgenic mice | |
Cavalieri et al. | Regulatory sequences driving expression of the sea urchin Otp homeobox gene in oral ectoderm cells | |
Sakaguchi et al. | Medaka unextended-fin mutants suggest a role for Hoxb8a in cell migration and osteoblast differentiation during appendage formation | |
KR20180037449A (en) | Brain tumor animal model and the Use thereof | |
CN110283847A (en) | A kind of while site-directed integration FAD3 and FABP4 gene carrier and recombinant cell | |
CN111704673B (en) | Fusion protein for marking microfilament framework, coding gene and construction method of transgenic leguminous plant | |
CN115322993B (en) | Safety site for site-directed integration of exogenous genes in pig genome and method for constructing pig breeding group by using safety site | |
CN113151181B (en) | Method for reprogramming adipose-derived stem cells into neurons and cell-adaptive hydrogel loaded with neurons for repairing spinal cord injury | |
Flowers et al. | Generating and identifying axolotls with targeted mutations using Cas9 RNA-guided nuclease | |
CN109321575B (en) | Pig adipose tissue specific promoter and application thereof | |
Chitramuthu et al. | Application of zebrafish and knockdown technology to define progranulin neuronal function | |
CN116083481A (en) | Application of ACVR2B in regulation and control of pork production performance and method for improving pork production performance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |